How-To Geek on MSN
6 niche programming languages developers secretly love
There are some languages that don't need mass appeal to be loved. Elixir, Lua, Zig, Clojure, Julia, and Rust prove that point ...
Hardwood, the project Gunnar Morling kick-started handling of Parquet files in Java, reached version 1. Its multi-threaded approach and zero mandatory external dependencies promise a simpler, more ...
These days, a lot of embedded projects feature some sort of screen, and a screen often creates a desire for a nice user interface. [Geoffrey Wells] has created a tool for developing web interfaces for ...
GigaDevice and Qt Group have entered a strategic partnership to simplify embedded GUI development. The companies will combine GigaDevice’s GD32H7 microcontroller family with Qt’s software framework ...
It might soon be "game over" for the video game controller. Yale researchers have developed a new kind of brain-computer interface (BCI) that lets humans play video games directly with their brains.
If you haven't seen the latest Java developer productivity report from Perforce, you should check it out. Written by Perforce CTO Rod Cope and developer tools exec Jeff Michael, the "2025 Java ...
JavaFX isn't hard to learn. In fact, any developer with a little bit of object-oriented knowledge and a penchant for desktop development in Java can quickly put together a feature-rich GUI application ...
OpenAI said it will acquire Astral, a startup that builds tools for software developers. Astral's team will join OpenAI as part of the group running its AI coding assistant, Codex. OpenAI has been ...
OpenAI Group PBC has invested in Merge Labs Inc., a startup developing hardware that will enable users to control computers with their thoughts. Merge Labs is building a brain-computer interface, or ...
AI on the JVM accelerates: New frameworks like Embabel, Koog, Spring AI, and LangChain4j drive rapid adoption of AI-native and AI-assisted development in Java. Java 25 anchors a modern baseline: The ...
The FDA has proposed cutting fees for early-stage companies conducting clinical development in the U.S. instead of abroad. The proposal is designed to incentivize U.S. drug development by tacking on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results